Elevance Health revenue and financials

ELV · NYSE · USD

$400.09+1.41%+$5.58

Close · October 6, 2026

In the fiscal year ended December 2025, Elevance Health reported revenue of $199.13B (+12.49% year over year). Net income was $5.66B, a net margin of 2.8%.

Annual revenue · 2025: $199.13B

$84.86B2016
$90.04B2017
$92.11B2018
$104.21B2019
$121.87B2020
$138.64B2021
$156.6B2022
$171.34B2023
$177.01B2024
$199.13B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth: +12.49%; 2025 vs 2024
Net income growth: −5.32%; 2025 vs 2024
Net margin: 2.8%; 2024: 3.4%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
Item	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Total revenue	50,474	50,181	49,747	50,711	49,776	—	—	—	—	—	—	—
EBIT	2,301	2,661	766	1,757	2,633	3,141	1,255	2,378	3,026	3,204	2,404	1,913
EBITDA	2,667	3,015	1,172	2,144	3,013	3,514	1,653	2,707	3,361	3,535	2,828	2,339
Interest expense	364	357	367	351	341	344	340	300	280	265	259	259
Pre-tax income	1,937	2,304	215	1,406	2,292	2,797	606	1,373	2,986	2,939	1,001	1,654
Income tax	483	544	-331	219	548	613	193	365	685	690	170	354
Net income	1,463	1,764	547	1,189	1,743	2,183	418	1,016	2,300	2,246	856	1,289
Net income to common shareholders	1,463	1,764	547	1,189	1,743	2,183	418	1,016	2,300	2,246	856	1,289
Basic EPS	6.74	8.03	2.47	5.32	7.74	9.64	1.81	4.38	9.91	9.65	3.63	5.48
Diluted EPS	6.71	8.00	2.47	5.32	7.72	9.61	1.81	4.36	9.85	9.59	3.63	5.45
Average shares (basic)	217	220	222	223	225	226	231	232	232	233	236	235
Average shares (diluted)	218	220	222	224	226	227	231	233	233	234	236	237
Dividend per share	1.72	1.72	1.71	1.71	1.71	1.71	1.63	1.63	1.63	1.63	1.48	1.48